AEON Biopharma Inc’s recently made public that its Director FISCHER JOST acquired Company’s shares for reported $29250.0 on May 21 ’25. In the deal valued at $0.49 per share,60,000 shares were bought. As a result of this transaction, FISCHER JOST now holds 266,785 shares worth roughly $0.19 million.
Then, FISCHER JOST bought 60,000 shares, generating $30,360 in total proceeds. Upon buying the shares at $0.51, the Director now owns 206,785 shares.
Before that, FISCHER JOST bought 50,000 shares. AEON Biopharma Inc shares valued at $24,940 were divested by the Director at a price of $0.50 per share. As a result of the transaction, FISCHER JOST now holds 146,785 shares, worth roughly $0.11 million.
H.C. Wainwright initiated its AEON Biopharma Inc [AEON] rating to a Buy in a research note published on August 18, 2023; the price target was $18.
Price Performance Review of AEON
On Friday, AEON Biopharma Inc [AMEX:AEON] saw its stock fall -5.93% to $0.73. Over the last five days, the stock has lost -4.96%. AEON Biopharma Inc shares have fallen nearly -98.91% since the year began. Nevertheless, the stocks have fallen -98.12% over the past one year. While a 52-week high of $115.57 was reached on 01/03/25, a 52-week low of $0.38 was recorded on 04/11/25.
Levels Of Support And Resistance For AEON Stock
The 24-hour chart illustrates a support level at 0.7133, which if violated will result in even more drops to 0.6950. On the upside, there is a resistance level at 0.7639. A further resistance level may holdings at 0.7962.
How much short interest is there in AEON Biopharma Inc?
A steep rise in short interest was recorded in AEON Biopharma Inc stocks on 2025-08-15, dropping by -0.11 million shares to a total of 0.25 million shares. Yahoo Finance data shows the prior-month short interest on 2025-07-15 was 0.36 million shares. There was a decline of -42.27%, which implies that there is a negative sentiment for the stock.
